IDSA, HIVMA Call for Transparency, Equitable Remdesivir Access

With FDA emergency authorization of remdesivir to treat COVID-19, the Infectious Diseases Society of America and its HIV Medicine Association are calling on Vice President Mike Pence and other administration officials to provide public transparency in the process for determining how and where the medication is distributed

IDSA, HIVMA Call for Strengthened Detention Facility Responses to COVID-19

With data showing alarmingly high rates of COVID-19 infection among people who are incarcerated, the Infectious Diseases Society of America and its HIV Medicine Association today released policy recommendations to prevent and respond to the spread of the coronavirus in detention settings.

Public Health, Medical Associations Call on Federal Authorities, State and Local Governments to Prioritize Safety in COVID-19 Policies

As leading public health and medical organizations, we represent front-line workers and experts who are witnessing the critical importance of maintaining physical distancing measures until data and resources indicate that lifting them is safe.

IDSA, HIVMA Recommend Criteria for Easing COVID-19 Control Efforts

The Infectious Diseases Society of America and its HIV Medicine Association warned today that prematurely easing social distancing measures put in place to curtail the spread of COVID-19 will risk increased infections and deaths, incapacitated health care facilities, and prolonged economic hardships.

Infectious Diseases Leaders Respond to President Trump’s Defunding of the World Health Organization

The unprecedented public health crisis of the COVID-19 pandemic demands a comprehensive international response. President Trump’s announcement Tuesday that he will suspend funding to the World Health Organization is against all of our best interests.

IDSA and HIVMA Lead Call for Data-driven Responses to COVID-19

IDSA and HIVMA welcome the president's extension of his projected duration for stay-at-home and physical distancing guidelines to last at least through April based on public health guidance, while calling for continued commitment to data-driven responses to the coronavirus.

As a New Pandemic Spreads, World TB Day Reminds us of Unfinished Business

In the midst of the new global health threat posed by COVID-19, this World TB Day reminds us that global efforts to control the world’s leading infectious disease killer must be accelerated to rid us of our oldest pandemic.

Nation's Infectious Diseases Leaders Send United Message

Infectious disease and HIV physicians, healthcare epidemiologists and other medical professionals on the frontlines defending our country from COVID-19 urgently need equipment and supplies to protect themselves, identify infections, treat patients, and save lives.

CARES Act Confronts Some Essential Needs, While Important Challenges Remain

With attention to diagnostic, treatment, health care and community needs that must be met if we are to reverse the trajectory of COVID-19 spread in the United States, the Coronavirus Aid, Relief, and Economic Security Act addresses some of the most critical challenges facing our country in the weeks and months ahead.

IDSA Statement On COVID-19 Testing Recommendations

The Infectious Diseases Society of America has developed recommendations for public health and health care professionals to prioritize testing for COVID-19 during the shortage of accessible tests and the continuing spread of the virus.

President's Budget Increases HIV Support, But Lacks Direction And Funding In Key Areas

President Trump’s fiscal year 2021 budget plan proposes $716 million in funding for the Ending the HIV Epidemic initiative – more than double the 2020 request.


Today Rep. John Lewis introduced the H.R. 5806, HIV Epidemic Loan-Repayment Program (HELP) Act with Rep. Barbara Lee and Rep. Frederica Wilson as original co-sponsors.